{"success":true,"data":{"pressRelease":{"id":"135087","rtpr_id":"nPnbWQXZ0a","ticker":"CLGN","exchange":"NASDAQ","all_tickers":["CLGN","CPTG"],"title":"COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR","author":"PR Newswire","published_at":"2026-09-03T12:00:11.433Z","article_body":"COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR\n\nPR Newswire\n\nREHOVOT, Israel, Sept. 3, 2026\n\n * Technological Edge - LightSolver advances the development of the world's first\nLaser Processing Unit (LPU) – an energy-efficient, pure photonic computing\nplatform\n * Accelerated Growth Path - The transaction positions LightSolver to accelerate\nits path towards commercialization and expand engagements with strategic\npartners.\nREHOVOT, Israel, Sept. 3, 2026 /PRNewswire/ -- CollPlant Biotechnologies\n(https://collplant.com/)  Ltd. (NASDAQ: CLGN) today announced the successful\nclosing of its previously announced acquisition of LightSolver\n(https://lightsolver.com/)  Ltd. (\"LightSolver\"), an Israeli deep-tech\ncompany pioneering a fundamentally new computing paradigm based on lasers.\n\nWith the closing of this transaction, CollPlant officially enters the\nhigh-performance computing (HPC) and photonics sectors. LightSolver's Laser\nProcessing Unit (LPU) is designed to accelerate some of the most\ncomputationally demanding workloads, while the transaction provides the\nresources to accelerate its commercialization, expand strategic partnerships,\nand advance LightSolver's long-term technology roadmap.\n\nExecutive Commentary\n\n\"We are pleased to complete this transaction with LightSolver, marking\nCollPlant's entry into the photonics computing sector,\" said Yehiel Tal,\nChairperson and Chief Executive Officer of CollPlant. \"This exciting new field\nof activity will run alongside our continued and active operations in\nregenerative medicine.\"\n\nDr. Ruti Ben Shlomi, Founder and Chief Executive Officer of LightSolver,\ncommented, \"Today marks an important milestone for our technology. We believe\nthis next chapter will help us accelerate our technology roadmap and pursue\ncommercial opportunities for our LPU platform globally. We remain focused on\nredefining the boundaries of computing speed and energy efficiency for our\npartners and the industry globally.\"\n\nTransaction Overview\n\nAs detailed in the definitive agreement announcement on August 31, 2026, the\nacquisition was completed utilizing an equity-centric consideration structure.\nAt closing, CollPlant among others issued upfront ordinary shares, pre-funded\nwarrants and an investment of $5 million in LightSolver. Additional\nmilestone-based warrants will become exercisable upon LightSolver's\nachievement of specified technological and commercial objectives.\n\nAdditional details about the transaction are available in the Company's Report\non Form 6-K, which was filed with the Securities and Exchange Commission on\nAugust 31, 2026.\n\nAbout LightSolver\n\nLightSolver is an Israeli deep-tech company pioneering a new generation of\nhigh-performance computing based on the physics of light. Founded in 2020 by\nWeizmann Institute physicists Dr. Ruti Ben Shlomi and Dr. Chene Tradonsky,\nLightSolver is the developer of the Laser Processing Unit™ (LPU™), a\nproprietary all-optical computing architecture that uses coupled lasers to\nperform computation.\n\nThe LPU™ is designed to accelerate computationally intensive workloads\nincluding scientific and engineering simulation, partial differential\nequations, large-scale linear systems and optimization, with applications\nacross aerospace, defense, energy, advanced engineering, financial services\nand Physical AI.\n\nLightSolver is advancing its technology toward commercial deployment in\ncollaboration with leading global organizations.\n\nFor more information about LightSolver, visit lightsolver.com.\n\nAbout CollPlant\n\nCollPlant is a pioneering technology company operating at the forefront of\nboth regenerative medicine and advanced high-performance computing. Following\nthe strategic acquisition of LightSolver, CollPlant has expanded its footprint\ninto the deep-tech sector, integrating a proprietary all-optical computing\narchitecture known as the Laser Processing Unit™ (LPU™). This bold\ndiversification positions the Company to address some of the world's most\ncomputationally intensive workloads across aerospace, defense, and Physical\nAI, while continuing to drive its core biotech innovations.\n\nIn the healthcare sector, CollPlant is ushering in a new era of medical\nsolutions with a focus on 3D bioprinting of tissues and organs, tissue repair,\nand medical aesthetics. The Company's products are based on its recombinant\nhuman collagen produced with CollPlant's proprietary plant-based genetic\nengineering technology, addressing indications for the diverse fields of\ntissue repair, aesthetics, and organ manufacturing.\n\nFor more information about CollPlant, visit collplant.com\n(http://www.collplant.com/) .\n\nForward-Looking Statements\n\nThis press release contains forward-looking statements within the meaning of\nthe Private Securities Litigation Reform Act of 1995. Forward-looking\nstatements include, but are not limited to, statements regarding the\nacquisition of LightSolver by CollPlant; the anticipated benefits, strategic\nrationale and growth opportunities arising from the transaction; LightSolver\nbecoming a subsidiary of CollPlant; the future development, commercialization\nand market adoption of LightSolver's Laser Processing Unit™ (LPU™)\ntechnology; and the future prospects, business plans and growth strategies of\nCollPlant, LightSolver and the combined business. Forward-looking statements\ncan be identified by words such as \"anticipate,\" \"believe,\" \"expect,\"\n\"intend,\" \"plan,\" \"may,\" \"should,\" \"could,\" \"might,\" \"seek,\" \"target,\" \"will,\"\n\"project,\" \"continue\" and similar expressions or the negative of such terms.\nThese forward-looking statements are based on assumptions and assessments made\nin light of management's experience and perception of historical trends,\ncurrent conditions, expected future developments and other factors believed to\nbe appropriate. Forward-looking statements are not guarantees of future\nperformance and are subject to risks and uncertainties, many of which are\noutside of our control. Many factors could cause our actual activities or\nresults to differ materially from the activities and results anticipated in\nforward- looking statements, including, but not limited to, the following: the\nability of the parties to satisfy the conditions to closing the transaction\nand consummate the transaction on the anticipated timeline or at all; the risk\nthat the anticipated benefits of the transaction are not realized, or are not\nrealized within the expected timeframe; risks associated with integrating\nLightSolver's business, operations and personnel; LightSolver's ability to\nachieve anticipated technological and commercial milestones; uncertainties\nregarding market acceptance and adoption of LightSolver's technology; the\nability to develop and commercialize LightSolver's products and technology\nsuccessfully; the ability to establish and expand strategic collaborations and\ncommercial relationships; competition and technological developments;\nintellectual property risks; the availability of capital; CollPlant's ability\nto maintain compliance with Nasdaq listing requirements; general market,\nindustry, economic and geopolitical conditions; and other risks and\nuncertainties described in CollPlant's filings with the U.S. Securities and\nExchange Commission, including its most recent Annual Report on Form 20-F and\nsubsequent Reports on Form 6-K. Forward-looking statements speak only as of\nthe date of this press release. CollPlant undertakes no obligation to update\nor revise any forward-looking statements, whether as a result of new\ninformation, future events or otherwise, except as required by applicable law.\n\nContact Information:\nCollPlant\nEran Rotem, Deputy CEO & CFO\nEmail: Eran@collplant.com (mailto:Eran@collplant.com)\n+972-73-2325600\n\nLightSolver Ltd.\nDr. Ruti Ben Shlomi, Founder & CEO\nEmail: Ruti@lightsolver.com (mailto:info@lightsolver.com)\n\n \n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/collplant-completes-acquisition-of-lightsolver-entering-the-photonic-computing-sector-302868948.html\n(https://www.prnewswire.com/news-releases/collplant-completes-acquisition-of-lightsolver-entering-the-photonic-computing-sector-302868948.html)\n\nSOURCE CollPlant\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1981190/LightSolver.jpg?id=OA2928359\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPnbWQXZ0a","title":"COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR","author":"PR Newswire","ticker":"CLGN","created":"2026-09-03T12:00:11.433Z","tickers":["CLGN","CPTG"],"exchange":"NASDAQ","article_body":"COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR\n\nPR Newswire\n\nREHOVOT, Israel, Sept. 3, 2026\n\n * Technological Edge - LightSolver advances the development of the world's first\nLaser Processing Unit (LPU) – an energy-efficient, pure photonic computing\nplatform\n * Accelerated Growth Path - The transaction positions LightSolver to accelerate\nits path towards commercialization and expand engagements with strategic\npartners.\nREHOVOT, Israel, Sept. 3, 2026 /PRNewswire/ -- CollPlant Biotechnologies\n(https://collplant.com/)  Ltd. (NASDAQ: CLGN) today announced the successful\nclosing of its previously announced acquisition of LightSolver\n(https://lightsolver.com/)  Ltd. (\"LightSolver\"), an Israeli deep-tech\ncompany pioneering a fundamentally new computing paradigm based on lasers.\n\nWith the closing of this transaction, CollPlant officially enters the\nhigh-performance computing (HPC) and photonics sectors. LightSolver's Laser\nProcessing Unit (LPU) is designed to accelerate some of the most\ncomputationally demanding workloads, while the transaction provides the\nresources to accelerate its commercialization, expand strategic partnerships,\nand advance LightSolver's long-term technology roadmap.\n\nExecutive Commentary\n\n\"We are pleased to complete this transaction with LightSolver, marking\nCollPlant's entry into the photonics computing sector,\" said Yehiel Tal,\nChairperson and Chief Executive Officer of CollPlant. \"This exciting new field\nof activity will run alongside our continued and active operations in\nregenerative medicine.\"\n\nDr. Ruti Ben Shlomi, Founder and Chief Executive Officer of LightSolver,\ncommented, \"Today marks an important milestone for our technology. We believe\nthis next chapter will help us accelerate our technology roadmap and pursue\ncommercial opportunities for our LPU platform globally. We remain focused on\nredefining the boundaries of computing speed and energy efficiency for our\npartners and the industry globally.\"\n\nTransaction Overview\n\nAs detailed in the definitive agreement announcement on August 31, 2026, the\nacquisition was completed utilizing an equity-centric consideration structure.\nAt closing, CollPlant among others issued upfront ordinary shares, pre-funded\nwarrants and an investment of $5 million in LightSolver. Additional\nmilestone-based warrants will become exercisable upon LightSolver's\nachievement of specified technological and commercial objectives.\n\nAdditional details about the transaction are available in the Company's Report\non Form 6-K, which was filed with the Securities and Exchange Commission on\nAugust 31, 2026.\n\nAbout LightSolver\n\nLightSolver is an Israeli deep-tech company pioneering a new generation of\nhigh-performance computing based on the physics of light. Founded in 2020 by\nWeizmann Institute physicists Dr. Ruti Ben Shlomi and Dr. Chene Tradonsky,\nLightSolver is the developer of the Laser Processing Unit™ (LPU™), a\nproprietary all-optical computing architecture that uses coupled lasers to\nperform computation.\n\nThe LPU™ is designed to accelerate computationally intensive workloads\nincluding scientific and engineering simulation, partial differential\nequations, large-scale linear systems and optimization, with applications\nacross aerospace, defense, energy, advanced engineering, financial services\nand Physical AI.\n\nLightSolver is advancing its technology toward commercial deployment in\ncollaboration with leading global organizations.\n\nFor more information about LightSolver, visit lightsolver.com.\n\nAbout CollPlant\n\nCollPlant is a pioneering technology company operating at the forefront of\nboth regenerative medicine and advanced high-performance computing. Following\nthe strategic acquisition of LightSolver, CollPlant has expanded its footprint\ninto the deep-tech sector, integrating a proprietary all-optical computing\narchitecture known as the Laser Processing Unit™ (LPU™). This bold\ndiversification positions the Company to address some of the world's most\ncomputationally intensive workloads across aerospace, defense, and Physical\nAI, while continuing to drive its core biotech innovations.\n\nIn the healthcare sector, CollPlant is ushering in a new era of medical\nsolutions with a focus on 3D bioprinting of tissues and organs, tissue repair,\nand medical aesthetics. The Company's products are based on its recombinant\nhuman collagen produced with CollPlant's proprietary plant-based genetic\nengineering technology, addressing indications for the diverse fields of\ntissue repair, aesthetics, and organ manufacturing.\n\nFor more information about CollPlant, visit collplant.com\n(http://www.collplant.com/) .\n\nForward-Looking Statements\n\nThis press release contains forward-looking statements within the meaning of\nthe Private Securities Litigation Reform Act of 1995. Forward-looking\nstatements include, but are not limited to, statements regarding the\nacquisition of LightSolver by CollPlant; the anticipated benefits, strategic\nrationale and growth opportunities arising from the transaction; LightSolver\nbecoming a subsidiary of CollPlant; the future development, commercialization\nand market adoption of LightSolver's Laser Processing Unit™ (LPU™)\ntechnology; and the future prospects, business plans and growth strategies of\nCollPlant, LightSolver and the combined business. Forward-looking statements\ncan be identified by words such as \"anticipate,\" \"believe,\" \"expect,\"\n\"intend,\" \"plan,\" \"may,\" \"should,\" \"could,\" \"might,\" \"seek,\" \"target,\" \"will,\"\n\"project,\" \"continue\" and similar expressions or the negative of such terms.\nThese forward-looking statements are based on assumptions and assessments made\nin light of management's experience and perception of historical trends,\ncurrent conditions, expected future developments and other factors believed to\nbe appropriate. Forward-looking statements are not guarantees of future\nperformance and are subject to risks and uncertainties, many of which are\noutside of our control. Many factors could cause our actual activities or\nresults to differ materially from the activities and results anticipated in\nforward- looking statements, including, but not limited to, the following: the\nability of the parties to satisfy the conditions to closing the transaction\nand consummate the transaction on the anticipated timeline or at all; the risk\nthat the anticipated benefits of the transaction are not realized, or are not\nrealized within the expected timeframe; risks associated with integrating\nLightSolver's business, operations and personnel; LightSolver's ability to\nachieve anticipated technological and commercial milestones; uncertainties\nregarding market acceptance and adoption of LightSolver's technology; the\nability to develop and commercialize LightSolver's products and technology\nsuccessfully; the ability to establish and expand strategic collaborations and\ncommercial relationships; competition and technological developments;\nintellectual property risks; the availability of capital; CollPlant's ability\nto maintain compliance with Nasdaq listing requirements; general market,\nindustry, economic and geopolitical conditions; and other risks and\nuncertainties described in CollPlant's filings with the U.S. Securities and\nExchange Commission, including its most recent Annual Report on Form 20-F and\nsubsequent Reports on Form 6-K. Forward-looking statements speak only as of\nthe date of this press release. CollPlant undertakes no obligation to update\nor revise any forward-looking statements, whether as a result of new\ninformation, future events or otherwise, except as required by applicable law.\n\nContact Information:\nCollPlant\nEran Rotem, Deputy CEO & CFO\nEmail: Eran@collplant.com (mailto:Eran@collplant.com)\n+972-73-2325600\n\nLightSolver Ltd.\nDr. Ruti Ben Shlomi, Founder & CEO\nEmail: Ruti@lightsolver.com (mailto:info@lightsolver.com)\n\n \n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/collplant-completes-acquisition-of-lightsolver-entering-the-photonic-computing-sector-302868948.html\n(https://www.prnewswire.com/news-releases/collplant-completes-acquisition-of-lightsolver-entering-the-photonic-computing-sector-302868948.html)\n\nSOURCE CollPlant\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1981190/LightSolver.jpg?id=OA2928359\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-09-03T12:00:11.478188957Z","server_sent_at_ms":1788436811478},"received_at":"2026-09-03T12:00:11.535Z","source_url":"https://www.prnewswire.com/news-releases/collplant-completes-acquisition-of-lightsolver-entering-the-photonic-computing-sector-302868948.html"},"analysis":{"id":"123972","press_release_id":"135087","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":["consideration largely in equity (ordinary shares plus pre-funded warrants) -- dilutive and total deal value undisclosed","LightSolver is pre-commercial with no revenue, milestone timeline, or commercialization dates provided","forward-looking statements flag CollPlant's ability to maintain Nasdaq listing compliance","strategic pivot diversifies away from core biotech focus into an unproven computing sector"],"eventType":"m_and_a","narrative":"CollPlant has completed its acquisition of LightSolver, an Israeli deep-tech company developing the Laser Processing Unit, a pure photonic computing platform aimed at high-performance computing workloads.\n\nConsideration was equity-centric: upfront ordinary shares, pre-funded warrants, and a $5 million investment in LightSolver at closing, with additional milestone-based warrants tied to future technological and commercial objectives.\n\nThe deal gives the small-cap biotech a growth narrative in photonics alongside its regenerative medicine business, but total deal value was not disclosed and LightSolver remains pre-commercial.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"Micro-cap biotech CollPlant closes all-equity acquisition of photonic computing startup LightSolver -- dilution and pre-commercial risk vs. a hot photonics narrative."},"keyFigures":{"customDimensions":{"closing_investment_usd":5000000,"consideration_structure":"equity-centric: upfront ordinary shares, pre-funded warrants, $5 million investment in LightSolver, plus milestone-based warrants"}},"quotedText":"Today marks an important milestone for our technology.","namedEntities":{"people":[{"name":"Yehiel Tal","role":"Chairperson and CEO of CollPlant"},{"name":"Dr. Ruti Ben Shlomi","role":"Founder and CEO of LightSolver"},{"name":"Dr. Chene Tradonsky","role":"Co-founder of LightSolver, Weizmann Institute physicist"},{"name":"Eran Rotem","role":"Deputy CEO & CFO of CollPlant"}],"products":["Laser Processing Unit™ (LPU™)","recombinant human collagen"],"companies":[{"name":"CollPlant Biotechnologies Ltd.","ticker":"CLGN","relationship":"filer / acquirer"},{"name":"LightSolver Ltd.","relationship":"acquired target, now subsidiary"},{"name":"Weizmann Institute","relationship":"academic affiliation of LightSolver founders (mentioned)"}],"dollarAmounts":[{"amount":"$5 million","context":"investment in LightSolver at closing"}]},"materialImpact":{"score":4,"reasoning":"Completed acquisition that transforms CollPlant's strategic profile by adding a pre-commercial photonic computing platform alongside its core biotech. Deal size is not disclosed and consideration is equity-centric (ordinary shares, pre-funded warrants, milestone warrants), so it is transformative but not clearly market-moving at score 5."},"tickerRelevance":{"others":[],"primary":"CLGN"},"globalImportance":28,"audienceRelevance":27,"eventTypeSecondary":["dilution"],"importanceComponents":{"themeBoost":"photonic computing is a retail-hyped theme","tickerTier":"small-cap foreign issuer (NASDAQ, Israel-based)","eventGravity":"completed M&A closing with strategic sector entry","issuerAuthored":true,"dilutionElement":true,"dealValueDisclosed":false}},"event_type":"m_and_a","event_type_secondary":["dilution"],"sentiment":"bullish","material_impact_score":4,"narrative":"CollPlant has completed its acquisition of LightSolver, an Israeli deep-tech company developing the Laser Processing Unit, a pure photonic computing platform aimed at high-performance computing workloads.\n\nConsideration was equity-centric: upfront ordinary shares, pre-funded warrants, and a $5 million investment in LightSolver at closing, with additional milestone-based warrants tied to future technological and commercial objectives.\n\nThe deal gives the small-cap biotech a growth narrative in photonics alongside its regenerative medicine business, but total deal value was not disclosed and LightSolver remains pre-commercial.","key_figures":{"customDimensions":{"closing_investment_usd":5000000,"consideration_structure":"equity-centric: upfront ordinary shares, pre-funded warrants, $5 million investment in LightSolver, plus milestone-based warrants"}},"named_entities":{"people":[{"name":"Yehiel Tal","role":"Chairperson and CEO of CollPlant"},{"name":"Dr. Ruti Ben Shlomi","role":"Founder and CEO of LightSolver"},{"name":"Dr. Chene Tradonsky","role":"Co-founder of LightSolver, Weizmann Institute physicist"},{"name":"Eran Rotem","role":"Deputy CEO & CFO of CollPlant"}],"products":["Laser Processing Unit™ (LPU™)","recombinant human collagen"],"companies":[{"name":"CollPlant Biotechnologies Ltd.","ticker":"CLGN","relationship":"filer / acquirer"},{"name":"LightSolver Ltd.","relationship":"acquired target, now subsidiary"},{"name":"Weizmann Institute","relationship":"academic affiliation of LightSolver founders (mentioned)"}],"dollarAmounts":[{"amount":"$5 million","context":"investment in LightSolver at closing"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-03T12:38:22.051Z","global_importance":28,"audience_relevance":27,"importance_components":{"themeBoost":"photonic computing is a retail-hyped theme","tickerTier":"small-cap foreign issuer (NASDAQ, Israel-based)","eventGravity":"completed M&A closing with strategic sector entry","issuerAuthored":true,"dilutionElement":true,"dealValueDisclosed":false}},"durationMs":269366,"modelName":"glm-4.7"}}